T2 Mapping

QUIBIM

QUIBIM has developed a fully automated tool to calculate the parameters related to the MR transverse relaxation time. The aim of QUIBIM Precision® Relaxometry T2 Mapping is to provide T2 relaxometry measurements and generation of parametric maps.
Product specifications Information source: Vendor
Last updated: March 10, 2020
General
Product name T2 Mapping
Company QUIBIM
Subspeciality Abdomen, Breast
Modality MR
Disease targeted Solid tumors, Prostate cancer, Rectal Cancer, Breast Cancer
Key-features T2 values, T2 Histogram
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand) (Need to draw ROI)
Data characteristics
Population Assessment and monitoring of solid tumors and cartilage changes
Input MRI T2 Multi-echo
Input format
Output One-page structured report: ROI, T2 map, T2 histogram, T2 fitting, statistics summary
Output format
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically after drawing ROI
Processing time 1 - 10 minutes
Certification
CE Certified, Class IIa
FDA No or not yet
Market presence
On market since 01-2019
Distribution channels
Countries present (clinical, non-research use) 2
Paying clinical customers (institutes) 5+
Research/test users (institutes)
Pricing
Pricing model License
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers Crema MD et al. Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research. RadioGraphics 2011;31:37-61.

Sanz-Requena R et al. Modification of longitudinal relaxation time (T1) as a biomarker of patellar cartilage degeneration. Radiologia 2010;52:221-227.

Sanz R et al. MR pharmacokinetic modeling of the patellar cartilage differentiates normal from pathological conditions. J Magn Reson Imaging 2008;27:171-177.